Literature DB >> 21869678

Caval inflow to the graft for liver transplantation in patients with diffuse portal vein thrombosis: a 12-year experience.

Prashant Bhangui1, Chetana Lim, Chady Salloum, Paola Andreani, Mylene Sebbagh, Emir Hoti, Philippe Ichai, Faouzi Saliba, Rene Adam, Denis Castaing, Daniel Azoulay.   

Abstract

OBJECTIVE: To analyze the short- and long-term results of cavoportal anastomosis (CPA) and renoportal anastomosis (RPA) in 20 consecutive liver transplantation (LT) candidates with diffuse portal vein thrombosis (PVT). SUMMARY BACKGROUND DATA: Caval inflow to the graft (CIG) by CPA or RPA has been the most commonly used salvage technique to overcome the absolute contraindication for LT in case of diffuse PVT.
METHODS: From 1996 to 2009, 3 patients (15%) underwent CPA and 17 patients (85%) had an RPA during LT. In addition to routine follow-up, patients were specifically evaluated for signs of portal hypertension (PHT) and for patency of the anastomoses. The follow-up ranged from 3 months to 12 years (median of 4.5 years).
RESULTS: : Caval inflow to the graft was feasible in all attempted cases. In the short term (<6 months), 35% of patients had residual PHT-related complications (massive ascites and variceal bleeding). These resolved spontaneously or with endoscopic management. Three deaths occurred; none was related to PHT or shunt thrombosis. In the long term (>6 months), 1 death occurred because of recurrent variceal bleeding after RPA thrombosis. At last follow-up, all living patients [n = 13 (65%)] had normal liver function, no signs of PHT and patent anastomoses. There were no retransplantations. Graft and patient survival at 1, 3, and 5 years were 83%, 75%, and 60%, respectively.
CONCLUSIONS: Caval inflow to the graft is an efficacious salvage technique with satisfactory long-term results, considering the spontaneous outcome in patients denied LT because of diffuse PVT. Adequate preoperative management of PHT and its associated complications is vital in obtaining good results. In the long term, residual PHT resolves and the liver function returns to normal.

Entities:  

Mesh:

Year:  2011        PMID: 21869678     DOI: 10.1097/SLA.0b013e31822d7894

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

Review 1.  From portal to splanchnic venous thrombosis: What surgeons should bear in mind.

Authors:  Quirino Lai; Gabriele Spoletini; Rafael S Pinheiro; Fabio Melandro; Nicola Guglielmo; Jan Lerut
Journal:  World J Hepatol       Date:  2014-08-27

Review 2.  Intestine and multivisceral transplantation: current status and future directions.

Authors:  Chandrashekhar A Kubal; Richard S Mangus; A Joseph Tector
Journal:  Curr Gastroenterol Rep       Date:  2015-01

3.  Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis.

Authors:  Jonathan G Stine; Curtis K Argo; Shawn J Pelletier; Daniel G Maluf; Patrick G Northup
Journal:  Transpl Int       Date:  2016-10-06       Impact factor: 3.782

4.  Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia.

Authors:  Faisal A Abaalkhail; Mohammed I Al Sebayel; Mohammed A Shagrani; Wael A O'Hali; Nasser M Almasri; Abduljaleel A Alalwan; Mohammed Y Alghamdi; Hamad Al-Bahili; Mohammed S AlQahtani; Saleh I Alabbad; Waleed K Al-Hamoudi; Saleh A Alqahtani
Journal:  Saudi Med J       Date:  2021-09       Impact factor: 1.422

Review 5.  Portal vein arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital experience.

Authors:  Prashant Bhangui; Chady Salloum; Chetana Lim; Paola Andreani; Arie Ariche; René Adam; Denis Castaing; Tech Kerba; Daniel Azoulay
Journal:  HPB (Oxford)       Date:  2013-12-12       Impact factor: 3.647

6.  Bleeding from jejunal varices formed at the Roux-en-Y jejunum site caused by the compression of the left renal vein after living donor liver transplantation with renoportal anastomosis.

Authors:  Wataru Nakanishi; Shigehito Miyagi; Kazuaki Tokodai; Atsushi Fujio; Toshiaki Kashiwadate; Kengo Sasaki; Yoshihiro Shono; Mineto Ohta; Yoshikatsu Saitoh; Michiaki Unno; Takashi Kamei
Journal:  Surg Case Rep       Date:  2021-02-06

7.  Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: Systematic Review and Meta-Analysis.

Authors:  Lucas S Nacif; Leonardo Y Zanini; Rafael S Pinheiro; Daniel R Waisberg; Vinicius Rocha-Santos; Wellington Andraus; Flair J Carrilho; Luiz Carneiro-D'Albuquerque
Journal:  Clinics (Sao Paulo)       Date:  2021-01-22       Impact factor: 2.365

8.  The Role of Cavoportal and Renoportal Hemitransposition in Liver Transplantation.

Authors:  Betty Maillot; Guillaume Bouzille; Jean-Yves Mabrut; Edouard Girard; Alexis Laurent; Francis Navarro; Alexandre Chebaro; Laurence Chiche; Francois Faitot; Laurent Sulpice; Eric Vibert; Karim Boudjema
Journal:  Ann Transplant       Date:  2022-03-08       Impact factor: 1.530

9.  Point of care perioperative coagulation management in liver transplantation and complete portal vein thrombosis.

Authors:  Cristiano Piangatelli; Lucia Faloia; Claudia Cristiani; Ilaria Valentini; Marco Vivarelli
Journal:  Case Rep Transplant       Date:  2014-02-06

10.  Systemic Venous Inflow to the Liver Allograft to Overcome Diffuse Splanchnic Venous Thrombosis.

Authors:  Cristian Lupascu; Tom Darius; Pierre Goffette; Jan Lerut
Journal:  Gastroenterol Res Pract       Date:  2015-10-11       Impact factor: 2.260

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.